← Back to Intel
Insider ActivityMLYS
Karydas Daphne, Director at Mineralys Therapeutics, Inc., sold $75K of MLYS
Updated Jun 11, 2026
Karydas Daphne
Director
Mineralys Therapeutics, Inc. ·
$MLYS
Transaction Details
| Insider | Karydas Daphne |
|---|---|
| Title | Director |
| Company | Mineralys Therapeutics, Inc. |
| Ticker | MLYS |
| Transaction Type | Sale |
| Transaction Date | 2026-03-31 |
| Shares Traded | 3,000 |
| Price Per Share | $25 |
| Total Value | $75K |
| Filed Date | 2026-04-02 |
| Accession Number | 0001816952-26-000002 |
Ownership Context
| Shares Owned After Transaction | 6,200 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001816952-26-000002
Other Insider Trades — MLYS
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Rodman David Malcom | Chief Medical Officer | traded | $6K | 2026-05-18 |
| Rodman David Malcom | Chief Medical Officer | sold | $11K | 2026-05-18 |
| Rodman David Malcom | Chief Medical Officer | traded | $36K | 2026-05-13 |
| Rodman David Malcom | Chief Medical Officer | sold | $402K | 2026-05-13 |
| Rodman David Malcom | Chief Medical Officer | traded | $59K | 2026-05-13 |
| Rodman David Malcom | Chief Medical Officer | sold | $186K | 2026-05-12 |
| Rodman David Malcom | Chief Medical Officer | traded | $7K | 2026-05-12 |
| Rodman David Malcom | Chief Medical Officer | traded | $35K | 2026-05-11 |
| Rodman David Malcom | Chief Medical Officer | sold | $65K | 2026-05-11 |
| Rodman David Malcom | Chief Medical Officer | traded | $6K | 2026-04-17 |
Other Trades by Karydas Daphne
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| CMPS | COMPASS Pathways plc | traded | — | 2026-05-27 |
| MLYS | Mineralys Therapeutics, Inc. | traded | $36K | 2026-03-31 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for MLYS — Mineralys Therapeutics, Inc. →
Track MLYS insider activity in real time on The Wire →
Get alerts when Karydas Daphne files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 11, 2026 at 07:22 UTC